Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
04/1995
04/12/1995EP0647277A1 Methods for using cks fusion proteins
04/12/1995EP0647275A1 Cloning and expression of gonadotropin-releasing hormone receptor
04/12/1995EP0647272A1 Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof
04/12/1995EP0647270A1 Novel malignant cell type markers of the interior nuclear matrix
04/12/1995EP0647139A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE)
04/12/1995EP0357672B1 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein
04/11/1995US5405941 Gene therapy; anticancer, antiinflammatory agents, autoimmune diseases, Alzheimers*s
04/11/1995US5405940 Isolated nonapeptides derived from MAGE genes and uses thereof
04/11/1995US5405785 Derivatives of cyclosporine A, antibodies directed thereto and uses thereof
04/11/1995US5405783 Removing photoremovable protective group from region of substrate, contacting with protected amino acid, repeating to form peptide
04/11/1995US5405748 Purification of the Gal/GalNAc lectin from a nonpathogenic form of the parasite
04/11/1995CA1335180C Anti-thrombin-binding substance monoclonal antibodies, hybridomas producing same, as well as purification process and assay of thrombin-binding substance making use of said monoclonal antibodies
04/06/1995WO1995009232A2 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their cns carrier, antibodies thereto, and uses thereof
04/06/1995WO1995009187A1 Monoclonal antibody and assay of denatured dna by using the same
04/06/1995WO1995009186A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas
04/06/1995WO1995009182A1 Protective antigens against parasites
04/06/1995WO1995009180A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response
04/06/1995WO1995007466A3 Biotin-analog conjugated antibodies for positive cell selection and release
04/06/1995DE4042408C2 Compsns. for enhancing embryo prodn. in livestock
04/06/1995CA2172729A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response
04/06/1995CA2172492A1 Protective antigens against parasites
04/05/1995EP0646794A1 Method of immunological assaying of human osteocalcin, reagent and kit therefor, antibody to human osteocalcin, hybridoma producing said antibody, and method of producing it
04/05/1995EP0646793A2 Methods for utilizing cell lines which lack human class II histocompatibility antigens
04/05/1995EP0646600A1 A cell growth-inhibiting protein
04/05/1995EP0646377A1 Albumin-conjugated tumour cell-free extracts, antigenic compositions comprising the same, related antibodies, and uses thereof
04/05/1995EP0646244A1 Immunoassay and test kit for thrombin-antithrombin iii complex
04/05/1995EP0646175A1 RECOMBINANT $i(PSEUDOMONAS) EXOTOXIN WITH INCREASED ACTIVITY
04/05/1995EP0646174A1 Recombinant production of saporin-containing proteins
04/05/1995EP0646173A1 Reagent for agglutination assays
04/05/1995EP0646129A1 Receptor-type tyrosine kinase-like molecules
04/05/1995EP0646014A1 The use of hyperimmune milk to increase longevity
04/05/1995EP0646010A1 Use of mullerian inhibiting substance for treating tumors and for modulating class 1 major histocompatibility antigen expression
04/05/1995EP0646000A1 Compositions using microencapsulated neutralizing antibodies
04/05/1995EP0507839B1 Method of separating haemopoietic progenitor cells
04/05/1995EP0318554B1 Targeted multifunctional proteins
04/05/1995EP0277212B1 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor
04/05/1995EP0180615B1 Novel atrial natriuretic/vasodilator polypeptides
04/05/1995CN1028114C Monoclonal antibody specific for adhesion function domain of phagocyte surface protein
04/04/1995US5403926 Hepatocellular carcinoma oncogene
04/04/1995US5403924 Taga gene and methods for detecting predisposition to peptic ulceration
04/04/1995US5403919 Monoclonal antibodies as inhibitors
04/04/1995US5403914 Biological mediators of immune functions
04/04/1995US5403718 Methods and antibodies for the immune capture and detection of Borrelia burgdorferi
04/04/1995US5403716 Method for measurement of tissue factor in high sensitivity and measurement kit therefor
04/04/1995US5403713 Administering detectable amount of labeled anti-elam-1 monoclonal antibody and detecting the label
03/1995
03/30/1995WO1995008771A1 Immobilization of chemically cross-linked proteins on solid supports
03/30/1995WO1995008646A1 Prenatal diagnosis by isolation of fetal granulocytes from maternal blood
03/30/1995WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof
03/30/1995WO1995008628A2 Nucleic acids encoding merosin, merosin fragments and uses thereof
03/30/1995WO1995008627A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds
03/30/1995WO1995008577A1 Retargeting antibodies
03/30/1995WO1995008576A1 Monoclonal antibodies against leukocyte-specific g-protein-coupled receptors
03/30/1995WO1995008575A1 Monoclonal antibodies specific for feline infectious peritonitis virus
03/30/1995WO1995008572A1 Interaction of t-cell receptors and antigen in autoimmune disease
03/30/1995WO1995008570A1 Chimeric proteins which block complement activation
03/30/1995WO1995008569A1 NOVEL PROTEIN sp38 AND CONTRACEPTIVE VACCINE
03/30/1995WO1995008566A1 Novel peptide
03/30/1995WO1995008562A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition
03/30/1995WO1995008336A1 Graves' ophthalmopathy associated antibodies, graves' ophthalmopathy orbital antigen, and methods of use thereof
03/30/1995DE4332596A1 Monoclonal antibodies
03/30/1995CA2172610A1 Chimeric proteins which block complement activation
03/30/1995CA2172512A1 Interaction of t-cell receptors and antigen in autoimmune disease
03/30/1995CA2172504A1 Prenatal diagnosis by isolation of fetal granulocytes from maternal blood
03/30/1995CA2172490A1 Receptor recognition factors, protein sequences and methods of use thereof
03/30/1995CA2172385A1 Nucleic acids encoding merosin, merosin fragments and uses thereof
03/30/1995CA2171607A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition
03/30/1995CA2171206A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds
03/30/1995CA2169620A1 Retargeting antibodies
03/30/1995CA2150029A1 Immobilization of chemically cross-linked proteins on solid supports
03/30/1995CA2149783A1 Novel peptides
03/29/1995EP0645628A1 Immunological detection method of pyrethroid compound, haptenic compound, intermediate for the haptenic compound, immunogen and antibody
03/29/1995EP0645450A1 Human calcitonin precursor polyprotein structural gene
03/29/1995EP0645147A1 Determination of lymph nodes enriched in tumor reactive cells, their proliferation, and their use in adoptive cellular therapy
03/29/1995EP0644948A1 Anti-receptor antibodies to the vitamin b12/transcobalamin ii receptor
03/29/1995EP0644947A1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses
03/29/1995EP0644936A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof
03/29/1995EP0644930A1 Monoclonal antibody against the extra-villous trophoblast
03/29/1995EP0644900A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
03/29/1995EP0644896A1 PEPTIDES REPRESENTING ANTIGENIC EPITOPES OF IgE PRESENT ON B CELL BUT NOT BASOPHIL SURFACE
03/29/1995EP0644895A1 Active component of parathyroid hypertensive factor
03/29/1995EP0644884A1 Novel tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
03/29/1995EP0644768A1 Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
03/29/1995EP0563144B1 Diagnosis for porcine malignant hyperthermia
03/29/1995EP0460190B1 Method for detecting malignant diseases
03/29/1995EP0403558B1 Antibodies for use in antilymphocyte antibody therapy
03/29/1995EP0393045B1 Fv antibody fragment production
03/29/1995CN1100656A Improved meningococcal polysaccharide conjugate vaccine
03/28/1995US5401831 Monoclonal antibodies for differentiating pathogenic and nonpathogenic E. histolytica
03/28/1995US5401828 Mutant genes present in malignant tumors, detection, tumor specific antibodies for treatment
03/28/1995US5401656 Screening for Rocky Mountain spotted fever and ehrlichiosis
03/28/1995US5401652 Nucleic acid sequence encoding apamin receptor protein
03/28/1995US5401638 Detection and quantification of neu related proteins in the biological fluids of humans
03/28/1995US5401635 Nucleic acids encoding human prohibitin mutants and detection thereof
03/28/1995US5401634 Stable biologically active fluorochemical emulsions
03/28/1995US5401628 Polypeptides derived from the human immunodeficiency virus endonuclease protein
03/28/1995US5401627 Warts, cancer
03/28/1995CA2108401A1 Receptor induced by lymphocyte activation in imflammatory response
03/28/1995CA2012631C Process for the production of hetero-bispecific antibodies
03/28/1995CA1334942C Production of m-csf
03/28/1995CA1334941C Cloning and expression of a host-protective immunogens of ibdv